Bio-Techne Corporation
US ˙ NasdaqGS ˙ US09073M1045

SecurityTECH / Bio-Techne Corporation
InstitutionRadnor Capital Management, LLC
Latest Disclosed Ownership6,890 shares
Latest Disclosed Value $ 360,071
Radnor Capital Management, LLC reports 63.48% decrease in ownership of TECH / Bio-Techne Corporation

On April 15, 2026 - Radnor Capital Management, LLC filed a 13F-HR form disclosing ownership of 6,890 shares of Bio-Techne Corporation (US:TECH) valued at $360,071 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 18,865 shares of Bio-Techne Corporation. This represents a change in shares of -63.48% during the quarter. The current value of the position is $350,356 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-15 2026-03-31 13F BIO-TECHNE COM 09073M104 6,890 -11,975 -63.48 360 -67.54 0.0533
2026-02-06 2025-12-31 13F BIO-TECHNE COM 09073M104 18,865 18,865 1,109 0.1647
2025-01-14 2024-12-31 13F BIO-TECHNE COM 09073M104 0 -2,645 -100.00 0 0.0000
2024-10-30 2024-09-30 13F BIO-TECHNE COM 09073M104 2,645 2,645 0 0.0313
2023-01-09 2022-12-31 13F BIO-TECHNE COM 09073M104 0 -1,688 -100.00 0 -100.00
2022-10-12 2022-09-30 13F BIO-TECHNE COM 09073M104 1,688 0 0.00 479 -18.12 0.1389
2022-07-11 2022-06-30 13F BIO-TECHNE COM 09073M104 1,688 0 0.00 585 -19.97 0.1600
2022-04-25 2022-03-31 13F BIO-TECHNE COM 09073M104 1,688 243 16.82 731 -2.27 0.1834
2022-01-20 2021-12-31 13F BIO-TECHNE COM 09073M104 1,445 530 57.92 748 68.85 0.1847
2021-10-26 2021-09-30 13F BIO-TECHNE COM 09073M104 915 0 0.00 443 7.52 0.2631
2021-07-21 2021-06-30 13F BIO-TECHNE COM 09073M104 915 -395 -30.15 412 -17.60 0.1391
2021-04-26 2021-03-31 13F BIO-TECHNE COM 09073M104 1,310 15 1.16 500 21.65 0.1608
2021-01-13 2020-12-31 13F BIO-TECHNE COM 09073M104 1,295 15 1.17 411 29.65 0.1159
2020-11-02 2020-09-30 13F BIO-TECHNE COM 09073M104 1,280 60 4.92 317 -2.46 0.1062
2020-07-28 2020-06-30 13F BIO-TECHNE COM 09073M104 1,220 1,220 325 0.1174
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.